SRC and thyroid cancer: Importantly, Src appears to be a primary regulator of the PI3K pathway in BRAF-mutant and RAS-mutant thyroid cancer cell lines, which is consistent with a reduction in this pathway upon inhibition of Src or the combined inhibition of Src and MEK1/2.